New-cost effectiveness evidence on nirmatrelvir/ritonaivir in the progression of COVID 19
The COVID-19 pandemic created an unprecedented burden on healthcare systems worldwide. At the annual meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID), Quantify Research own Martina Aldvén and Marcelina Kądziela in collaboration with Pfizer presented […]